Zhugen Yang Group
Advanced Sensors for Water-Environment-Health at Cranfield
  • Home
  • People
    • Zhugen Yang
  • Publication
  • Research
  • Facilites
  • News
    • Media coverages
  • Join us
  • Contact

 Advanced Sensors for Water, Environment & Health

Our multidisciplinary team focuses on the development of low-cost, rapid and point-of-use sensors and devices for environmental science (e.g. microbial contamination in drinking water), public health (e.g. drug of abuse, community infectious), and biomedical diagnostics (e.g. infectious disease and cancer), including the following areas. 
  • ​Point-of-use sensors and devices (e.g. Paper-based device)
  • Water Quality, environmental and public Health (e.g. microbial source tracking, wastewater-based epidemiology)
  • Molecular diagnostics for biomedicine and environmental health; 
Picture

Paper-based device 

The health and well-being of cattle is a significant concern for global agricultural output. In dairy production within low and middle income countries (LMICs), there is a significant biosensing challenge in detecting sexually transmitted infection (STI) pathogens during animal husbandry, due in part to difficulties associated with the limited infrastructure for veterinary medicine...
View more

Biomedical Diagnosis

Molecules adsorbed, and biochemical reaction, on a functionalized microcantilever cause vibrational frequency changes and static deflections of the microcantilever, and can be sensitively measured by detecting changes like surface deflection ....

​

view more

Community Sewage Sensors for Public Health

We aim to develop multichannel biosensors for human biomarker detection. We have proposed for the first of time, the concept of community sewage sensors for the detection of sewage biomarkers for monitoring public health via wastewater-based epidemiology (WBE), due to its rapid response times, low cost and minimal sample processing...
View More

Surface Chemistry and Protein Microarray 

Cancer is the first leading cause of death in the world, but the chance of cure will substantially increase if it can be precisely detected at an early stage. It has been observed that the sera of cancer patients contain autoantibodies against tumor-associated antigens (TAAs), which can be detected before clinical symptoms occur....
view more
Powered by Create your own unique website with customizable templates.